INS and Obesity: Although preclinical studies in rodent models have provided extensive insights into the anti-obesity mechanisms of plant-derived polysaccharides, including effects on lipid metabolism, insulin sensitivity, and gut microbiota modulation, translational validation in human populations remains essential for evaluating their clinical potential.